Skip to main content

35624™ Science

Bifidobacterium longum 35624

Formerly known as Bifidobacterium infantis 35624

  • Originally isolated from a healthy human gut1, 2
  • Safe, well tolerated1-3
  • Clinically proven to survive transit through the human gut4-7
  • Included in international clinical guidelines for management of IBS and lower gastrointestinal symptoms8, 9

35624®currently has the best evidence base for efficacy in IBS” World Gastroenterology Organisation, 20169
Learn More

  • Clinically studied in double-blind, placebo controlled trials7, 10 and real-world research11 in people with irritable bowel syndrome (IBS)
  • Shown to significantly improve IBS symptom scores including abdominal pain, bloating, and bowel movement difficulty7, 10 and may be associated with improved quality of life11
  • Shown to modulate dysregulated cytokine profile in IBS and inflammatory conditions including ulcerative colitis, psoriasis and chronic fatigue syndrome12
  • Learn more about the gut microbiome and gut health

Learn More in the Resource Centre

Other Strains

Clinically shown to improve the ability to cope with stress and reduce anxiety

Clinically shown to help manage IBS symptoms, depression, anxiety and quality of life

Preclinical evidence in the management of viral respiratory infections

We use cookies to ensure that we give you the best experience on our website. Please confirm you are happy to continue.